Working to Eradicate Gynecologic Cancers

Warner K. Huh, MD

Professor of Gynecologic Oncology
University of Alabama at Birmingham
Dept. of OB/GYN
1201 11th Ave
Birmingham, AL
USA 35205


Biographical Sketch:
All authors serve on the Data Steering Committee for the ATHENA trial. Two of the authors (TCW and WKH) have served or currently serve on leadership positions for the ASCCP.

Papers:
70 - Focused Plenary Phase I evaluation of therapeutic HPV16 E7 vaccination before resection of HPV16+ CIN2/3 97 - Featured Poster A phase II trial of intraperitoneal EGEN-001, an interleukin (IL)-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: a GOG study 158 - Poster Session A High rates of cervical intraepithelial neoplasia (CIN) 3 in young women undergoing immediate excisional procedure for high-grade squamous intraepithelial lesion (HSIL) cytology 287 - Poster Session A Testing the accuracy of mutation detection for the prevention of ovarian neoplasia: the TAMPON study 355 - Poster Session B National Comprehensive Cancer Network (NCCN) guidelines for gynecologic malignancies: where's the beef? 407 - Poster Session B Barriers to cervical cancer screening in victims of intimate partner violence: a Gynecologic Oncology Fellows Research Network study 409 - Poster Session B Black race independently predicts worse survival in uterine carcinosarcoma Lecturette 2013 Annual Meeting and 2014 Winter Meeting Award Presentation